Zinc and iron supplementation trials in Nepal and Tanzania [9]

Lancet

Volumn 367, Issue 9513, 2006, Pages 816-

  De Benoist, Bruno ^a   Darnton Hill, Ian ^b   Lynch, Sean ^c   Allen, Lindsay ^d   Savioli, Lorenzo ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNICEF   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; IRON; ZINC;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; CLINICAL TRIAL; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; IRON DEFICIENCY; IRON THERAPY; LETTER; MALARIA CONTROL; NEPAL; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TANZANIA; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

EID: 33644844368     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68334-7     Document Type: Letter

References (2)

1. S Sazawal, RE Black, M Ramsan Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial Lancet 367 2006 133 143
2. JM Tielsch, S Khatry, R Stoltzfus Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: community-based, cluster-randomised, placebo-controlled trial Lancet 367 2006 144 152